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Abstract- Introduction: Since the first official case of COVID-19 in China in December 2019, researchers have been trying 
to uncover the mechanism of action of the severe acute respiratory syndrome Coronavirus 2 (Sars-CoV-2), which attacks 
several organs in addition to the lungs and causes circulatory changes that can lead to death not only from lung failure but 
also due to commitment of other organs. Objective: The aim of this study is to find out the neurological consequences of 
COVID-19. Material and methods: A systematic review of the literature was concretised by mobilizing the descriptors: 
"Sars-Cov-2", "coronavirus infections" and "Neurological Consequences". Databases were selected and seven articles were 
included for analysis. Results and discussion: Although the effects of Sars-CoV-2 on the lung are exemplary and frightening, 
the long-term effects on the nervous system may be greater and even more overwhelming, as the regeneration of nerve 
tissue is difficult and can lead to general disability, as the nervous system coordinates the functions of the entire body. All 
studies show the presence of any kind of injury (mild or severe) to Central Nervous System, but some of them highlight the 
need for further studies to have great certainty. Conclusion: It can be said that the studies all agree on the possibility of 
existing neurological sequelae and a majority agree on the need for other studies. 
 




A new variant of coronavirus, Sars-CoV-2, which began in Wuhan, China, at the end of 2019, has since spread worldwide. 
The virus has caused an outbreak of viral pneumonia known as coronavirus disease (COVID-19). By February 6, 2020, 
more than 31000 cases and 636 deaths had been confirmed in China on January 23, 2020. The Chinese authorities imposed 
a lockdown of Wuhan (National Health Commission of the People's Republic of China (NHCPRC), 2020). On January 30, 
2020, the World Health Organization (WHO) declared the outbreak to be Public Health Emergency of International Concern 
(World Health Organization (WHO), 2020) and on March 11, 2020, a pandemic (WHO, 2020). 
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The WHO (2020), the United States Centers for Disease Control and Prevention (United States Centers for Disease Control 
and Prevention (USCDC, 2019), the European Center for Disease Prevention and Control (ECDC, 2020) and Chinese 
researchers have issued several guides or guidelines to help control the outbreaks. 
Sars-CoV-2 has elevated transmissibility and an asymptomatic incubation period during which transmission may develop 
(Huang et al. 2020; Rothe et al. 2020). Due to its peculiarities, more than 200 countries were affected by this disease by 19 
June 2020 (Centers for Disease Control and Prevention, 2020), resulting in the most relevant pandemic in current history. 
Previous publications have highlighted that coronavirus infections of severe acute respiratory syndrome and Middle East 
respiratory syndrome (MERS) have led to an increased prevalence of long-term neurological effects (Hong at al., 2020, Lee 
et al., 2020). 
When the pandemic COVID-19 shot around the globe, it suddenly became clear that it was not an average respiratory 
disease. The disease occurs and affects a number of body systems, including the heart and brain. At the beginning of the 
pandemic, there were reports that many people with the disease had lost their sense of smell, a strange symptom that suggests 
the virus could affect the nervous system. As more people became infected, there were reports of strokes and other 
neurological complexes. It is not yet clear how common neurological side effects are in hospitalized patients, let alone in 
people with less severe respiratory symptoms who do not spend time in hospital (Weir, 2020). Despite all efforts in this 
direction, there is certainly still much to discover in this context. 
 
 
II. MATERIALS AND METHODS     
A systematic review of the literature is one of the research methods used in the practice of evidence-based research, and its 
purpose is to collect and summarize research findings on a particular topic in a systematic and orderly manner, thereby 
contributing to knowledge about the topic (Mendes et al., 2008; Benefield, 2003). The method used was based on the 
strategy PICO (acronym for patient, intervention, comparison and "outcomes"). In this way it maximizes the inclusion of 
relevant information in different databases, focusing on the research object and avoiding unnecessary searches (Santos, 
Pimenta e Nobre, 2007). 
In strict compliance with all the steps required for the application of this method, a protocol was developed between 
September and November 2020 to identify studies of interest for this work, consisting of a search in the search engines: 
Ebsco and B-ONline and in the following databases: CINAHL Plus, PubMed/ MEDLINE, LILACS, Scielo, Web of Science, 
ScienceDirect and Repository of Scientific Open Access of Portugal. 
A search strategy using the following descriptors was used to identify relevant studies: "Sars-Cov-2" and "Coronavirus 
infections" and "Neurological Consequences". After all these protocol requirements were met, some articles that did not 




Seven articles have been selected for the study, which follow in Table 1. 
Table 1: Description of selected studies and main results of the investigations 
 





have we learned and 
where do we go 
from here? 
 
Abbas Jarrahi, Meenakshi 
Ahluwalia, Hesam 
Khodadadi, Evila da Silva 
Lopes Salles, Ravindra 
Kolhe, David C. Hess, 
Fernando Vale, Manish 
Kumar, Babak Baban, 
Kumar Vaibhav,  Krishnan 
M. Dhandapani, 2020 
-COVID-19, caused by the recent Sars-CoV-2 virus, is associated with a broad 
pathophysiology that has led to global mortality and morbidity.  
-Although Sars-CoV-2 is primarily considered a respiratory virus, it causes far-reaching and 
sometimes unpredictable neurological symptoms ranging from anosmia to encephalitis and 
an increased risk of stroke.  
-Improved advances, validation and implementation of rapid imaging techniques, such as 
magnetic resonance imaging (MRI), can contribute to early diagnosis and proactive 
intervention to limit the long-term neurological consequences.  
-Study proposes a future analysis defining whether Sars-CoV-2 exhibits neurotropism 
and/or initiates peripheral immune activation and hypercoagulation to impair brain 
function, which will be of paramount importance for the development of effective therapies 
to mitigate the deleterious neurological consequences of COVID -19, including potential 
benefits in the treatment of acute respiratory failure. 
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Ross W Paterson, Rachel L 
Brown, Laura Benjamin, 
Ross Nortley, Sarah 
Wiethoff, Tehmina 
Bharucha, Dipa L 
Jayaseelan, Guru Kumar, 
Rhian E Raftopoulos, Laura 
Zambreanu, Vinojini 
Vivekanandam, Anthony 
Khoo, Ruth Geraldes, 
Krishna Chinthapalli, Elena 
Boyd, Hatice Tuzlali, Gary 
Price, et al., 2020 
 
-COVID-19 infection is associated with a wide range of neurological syndromes that affect 
the entire neuraxis, including the cerebral vessels and in some cases the response to 
immunotherapy.  
-The high incidence of acute disseminated encephalomyelitis, particularly with 
haemorrhagic changes, is striking. This complication was not related to the severity of the 
respiratory disease COVID -19. Early detection, examination and treatment of the 
neurological disease associated with COVID -19 is a challenge.  
-They suggest that further clinical, neuroradiological, biomarker-based and 
neuropathological studies are essential to determine the underlying pathobiological 
mechanisms that will guide treatment. To determine the long-term neurological and 
neuropsychological consequences of this pandemic, longitudinal follow-up studies are 
needed. 
S3: Effects of COVID-
19 on the Nervous 
System 
Costantino Iadecola, Josef 
Anrather, Hooman Kamel, 
2020 
-It cloud concluded that the neurological manifestations of COVID -19 pose a major public 
health challenge, not only because of the acute effects on the brain, but also because of the 
long-term damage to brain health that may result.  
-These delayed manifestations are expected to be significant, as they are likely to affect 
patients who did not show neurological symptoms in the acute phase.  
-Therefore, clinical and laboratory efforts to elucidate the mechanisms of the acute effects 
of Sars-CoV-2 on the brain must be coupled with studies of the deleterious delayed 









Angélique Gruters, Yindee 
van O, Sonja Verstraeten, 
Susanne Valentijn, Rudolf 
Ponds and Marjolein de 
Vugt, 2020 
-Was concluded that neurological manifestations of COVID -19 vary from mild, such as 
headaches and dizziness, to severe, such as ischemic stroke and encephalitis. It is believed 
that the underlying mechanisms of CNS involvement are both direct (neurotropic) and 
indirect (as a result of thrombotic complications, inflammatory consequences, hypoxia, 
blood pressure dysregulation).  
No literature was found on the cognitive consequences of COVID -19. 
-Therefore cross-sectional and longitudinal studies are necessary. A neuropsychological 
assessment could be used to monitor the course of cognitive functions after recovery from 
COVID -19.  
-This should be conducted not only in inpatients COVID -19 but also include community-






Edward J. Needham, 
Sherry H.-Y. Chou, Alasdair 
J. Coles, and David K. 
Menon, 2020 
-Study indicates that although corona viruses are not a common cause of neurological 
disease, they are reported to cause direct CNS infection and suspected parainfectious 
disorders. More than one million cases of confirmed COVID -19 have been reported 
worldwide, and although there is little definitive evidence, new publications and preprints 
justify a careful review of the neurological links with infection from COVID -19. 
-The symptoms described (dizziness, headache and loss of consciousness) are common in 
many serious infections and are more likely to be disorders of neurological function than a 
neurological disorder per se. Anosmia and ageusia have received much attention, but are 
omnipresent in other common upper respiratory tract infections.  
-Risk for cerebrovascular disease was replicated in another preprint, the incidence was 
similar to critical illness in a broader sense. Another case report documented necrotising 
encephalopathy in conjunction with COVID -19, but without evidence of viral isolation from 
cerebrospinal fluid (CSF). 
-A greater concern than direct viral invasion of the CNS may be para-infectious neurological 
diseases such as Guillain-Barré syndrome, transverse myelitis or acute disseminated 
encephalomyelitis may be a greater problem than direct viral invasion of the CNS. 
-Patients with neurological complications may require lengthy intensive care stays and may 






Georgios Tsivgoulis, Lina 
Palaiodimou, Aristeidis H. 
Katsanos, Valeria Caso, 
Martin Köhrmann, Carlos 
Molina, Charlotte 
Cordonnier, Urs Fischer, 
-Research results from the current pandemic are accumulating and reporting COVID -19 
patients who presented with dizziness, headache, myalgia, hypogesia and hyposmia, but 
also with more serious manifestations such as polyneuropathy, myositis, cerebrovascular 
disease, encephalitis and encephalopathy.  
-However, it is often difficult to differentiate between causality and accidental comorbidity.  
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Peter Kelly, Vijay K. 
Sharma, Amanda C. Chan, 
Ramin Zand, Amrou Sarraj, 
Peter D. Schellinger, 
Konstantinos I. 
Voumvourakis, Nikolaos 
Grigoriadis, Andrei V. 
Alexandrov, and Sotirios 
Tsiodras, 2020 
 
-Severity COVID -19 shares common risk factors with cerebrovascular disease, and it is 
currently unclear whether infection in itself is an independent stroke risk factor.  
-Irrespective of any direct or indirect neurological manifestations, pandemic COVID -19 has 








Benedict Daniel Michael,  
Ava Easton, 
et al., 2020 
-The study reveals that, given the existing knowledge about other coronavirus and 
respiratory viruses, the broad spectrum of CNS associations with COVID -19 is not surprising, 
and this is the focus of most recent reports.  
-Case-control studies will be required to determine whether Sars-CoV-2 occurs causally or 
randomly in such patients. Hypercoagulable states and cerebrovascular disease, rarely 
observed in some acute viral infections, are an important neurological complication of 
COVID -19. 
-Neurological complications, particularly encephalitis and stroke, can lead to lifelong 
disability, with the associated need for care and potentially high health, social and economic 
costs. Health planners and decision-makers in the health care sector need to be aware of 
the growing burden. 
-Careful clinical, diagnostic and epidemiological studies are needed to define the 





Recent publications in the New England Journal of Medicine and Brain document neurological symptoms in patients with 
COVID-19. They range from simple cognitive difficulties to mental confusion, as well as headache, loss of smell, but also 
encephalitis, bleeding, thrombosis, ischaemic stroke and Guillain-Barre Syndrome (a disorder in which the immune system 
attacks the nerves of the body), neurological conditions that are not always correlated with the severity of respiratory 
symptoms (Comoli, Fukugava, Matos, 2020). This information is confirmed by all studies, in particular S1, S2, S4, S5, S7. 
However, none of these studies detected a virus in CSF, as in the S2 and S5 studies, where the results were negative for the 
presence of CSF. 
Where a number of neurological manifestations were reported, in a review of case reports from 901 COVID -19 patients, 
including loss of sense of smell and taste, confusion, encephalitis and Guillain-Barré syndrome. A case report of 58 patients 
from France retained neurological findings in 67% of patients (Helms, et al., 2020). The symptoms are manifold, including 
headache, dizziness, weakness, confusion, eye movement disorders, seizures and paralysis. This fact is confirmed by all 
studies. The two most common neurological problems appear to be stroke and delirium (Fotuhi, 2020). This is particularly 
true for studies S1, S2, S4, S5 and S7. 
People who need intensive care are more likely to have long-term cognitive problems and an increased risk of anxiety and 
depression. A study conducted before COVID-19 found that 20-40% of patients in intensive care units suffered from 
delirium, with rates rising to 60-80% in patients on ventilators (Pandharipande et al., 2017). It is assumed that such 
complications are related to both a serious illness and intensive care treatment. Some of the people with COVID -19 severe 
illness are likely to suffer from delirium and other neurological side effects from their stay in intensive care alone (Stevens, 
2020). As stated in S5 and S7. 
There are some reports of the virus appearing in the CSF, which increases the potential for Sars-CoV-2, the virus that causes 
COVID -19, to be able to directly infect brain cells. These facts speak against the S2 and S5 studies. But evidence that the 
virus can find its way into brain cells is still uncertain (Fotuhi, 2020; Stevens, 2020). As all the studies have concluded, 
further studies are needed. 
Today, as we are still experiencing the pandemic and its effects, it is too early to describe the full clinical picture. However, 
it is believed that the published evidence has already proven to be an indisputable case for medicine to identify the growing 
number of ex-patients with post-COVID Neurological Syndrome and the need for continuous neurological and 
cognitive/effective monitoring of all cases (regardless of severity from asymptomatic, mild to severe) (Wijerate, Sales, 
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Crewther et al., 2020). As emphasised in all studies, the S3 study in particular emphasises the importance of continuous 
monitoring of 19 patients after delivery, including patients who have not been admitted to a health care unit. 
Recent publications highlight new evidence of a new syndrome, Post-COVID-19 Neurological Syndrome (PCNS), 
specifying patients with long-term muscle weakness and other forms of myopathy among survivors of Sars-CoV-2 in Hong 
Kong (Chang et al., 2003). It is also worth noting that the more delayed effects of Sars-CoV-2 infection affect the nervous 
system and its combined effect on mental status.  
A further study of 714 COVID -19 patients in China found that almost 97% of patients exhibited symptoms of severe 
posttraumatic stress disorder (Bo et al., 2020). As the S7 study found, the experience can be disabling and restrictive for the 
rest of the patients' lives. 
The prevalence of neurological problems remains an open question, but it is certain that neurological injuries are not 
uncommon in OVC-19 patients (Fotuhi, 2020). This is undoubtedly the sentence that answers the aim of this review and 




Regarding the results of the studies analysed, it can be stated that all studies agree on the possibility of existing neurological 
consequences and on the need for other studies. Possible neurological lesions vary in the studies and may be mild or severe. 
The pandemic COVID-19 is a serious global public health challenge. Since the first appearance of a novel coronavirus in 
late 2019, Sars-CoV-2 has spread recklessly and affected almost every aspect of society worldwide, with a broad 
pathophysiology that has led to global mortality and morbidity. Although Sars-CoV-2 is primarily considered to be a 
respiratory virus, it produces far-reaching and often unpredictable neurological symptoms ranging from anosmia to 
encephalitis to an increased risk of stroke, making clinical treatment difficult. Improved development, validation and 
implementation of rapid imaging techniques, such as MRI, can help with early diagnosis and proactive intervention, 
including long-term neurological consequences. 
New studies based on biological variables such as gender, age, comorbidities (e.g. hypertension, diabetes), pre-existing 
neurological disorders and other yet undefined genetic polymorphisms determine the clinical course of Sars-CoV-2 
infection. This unbiased, population-wide research will provide valuable information that will guide practice in dealing with 
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